From the first day of its establishment, Clindata® has been committed to helping small and medium-sized innovative drug companies in China to solve the "stuck neck" problem of clinical trial plans and design strategies, and has turned customers into global leaders in innovative drug research and development. The purpose of the company is to keep the patient as the center, to achieve the original intention of human health through scientific clinical practice, and to keep in mind the mission of developing new drugs to cure tumors and other major diseases.

——Jack Guo

Founder and CEO of Clindata^®